Brief: Collegium Pharmaceutical Outlook FY Adjusted EBITDA USD 380-395 Million
03/01/2024 13:00
Jan 03 (Reuters) - Collegium Pharmaceutical outlook FY revenue USD 580-595 million
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%